(secondQuint)Study of Single Dose GHB16L2 Trivalent Influenza Vaccine in Healthy Adults.

 GHB16L2 intends to provide a novel vaccination for influenza virus infection.

 80 healthy volunteers will be included at a ratio of 1:1 for GHB16L2 or placebo.

 GHB16L2 will be administered once on day 1.

 Follow-up visits will be performed on days 2, 8 and 29.

.

 Study of Single Dose GHB16L2 Trivalent Influenza Vaccine in Healthy Adults@highlight

The purpose of this phase I/II trial is to evaluate safety and tolerability of a single dose of GHB16L2 administered by liquid nasal spray for vaccination against seasonal influenza virus infection.

 It is also performed to assess immunogenicity and pharmacokinetics (shedding).

